Stock Market News

5 hours Wait for longer-term data with Amgen’s GLP-1, says Piper Sandler’s Christopher RaymondYouTube

Wait for longer-term data with Amgen’s GLP-1, says Piper Sandler’s Christopher Raymond.

Amgen (AMGN)

5 hours Final Trade: JWN, IWM, GCO, AMGNYouTube X

8 hours Amgen stock sinks as weightloss drug fails to impressFXStreet X

9 hours Amgen: MariTide Underwhelms, But There Are Ways To WinSeeking Alpha X

10 hours Chart of the Day: AmgenYouTube X

13 hours Cramer’s Stop Trading: AmgenYouTube X

14 hours Amgen Stock Dives After Weight-Loss Drug Data. Here’s What to Know.Yahoo Finance X

15 hours Amgen Dives 5% Despite ‘Truly Remarkable’ Results For Obesity TreatmentInvestor's Business Daily X

15 hours Amgen Stock Dives Despite Positive Weight-Loss Drug Data. What to Know.Yahoo Finance X

16 hours Amgen says obesity drug caused up to 20% weight loss after a year, with no plateauYouTube X

19 hours These Stocks Are Moving the Most Today: GM, Ford, Amgen, Eli Lilly, Super Micro, Best Buy, Analog Devices, Kohl’s, Semtech, and MoreYahoo Finance X

5 days Why Amgen (AMGN) is a Top Value Stock for the Long-TermZacks X

1 week Amgen Sells Off: Keep Calm And Buy The DipSeeking Alpha X

1 week Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on ItZacks X

2 weeks 2 Reasons to Buy Amgen Stock, and 1 Reason to Be CautiousThe Motley Fool X

2 weeks Amgen, Merck stocks dive as Trump picks anti-vaxxer RFK Jr. to lead US healthcareFXStreet X

2 weeks Amgen Shrugs Off Bone Density Concerns Related to Obesity CandidateZacks X

2 weeks Amgen Inc. (AMGN) UBS Global Healthcare Conference (Transcript)Seeking Alpha X

2 weeks Trade Tracker: Joe Terranova sells Amgen and buys XBIYouTube X

2 weeks Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?Investor's Business Daily X

2 weeks Amgen dismisses bone density concerns related to its new weight-loss drugInvesting.com X

2 weeks Amgen sinks as Cantor flags issues with obesity drugYouTube X

2 weeks Amgen stock falls as analysts mull over weight loss drug’s bone density dataCNBC X

2 weeks Amgen Drops 7% After A ‘Big Unknown Risk’ Rattles Its Monthly Obesity ShotInvestor's Business Daily X

3 weeks Big Pharma’s Obesity Bonanza Faces New TestsThe Wall Street Journal X

3 weeks Amgen: A Biotech Giant Offering Value And Growth In A Frothy MarketSeeking Alpha X

4 weeks Analyst Report: AMGEN Inc.Yahoo Finance X

4 weeks Market Digest: AAPL, AMGN, AMP, BBY, CTSH, EPD, MCO, UNP, MA, VRSK, PPC, GEHCYahoo Finance X

4 weeks Amgen Inc. (AMGN) Q3 2024 Earnings Call TranscriptSeeking Alpha X

4 weeks Amgen Inc. 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X

4 weeks Amgen (AMGN) Q3 2024 Earnings Call TranscriptThe Motley Fool X

4 weeks Amgen ‘Laser-Focused’ On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFOInvestor's Business Daily X

4 weeks Amgen beats Q3 earnings estimates, raises full-year guidanceInvesting.com X

4 weeks Pfizer Unveils Its Next Black Box In Obesity. It’s Taking On Amgen.Investor's Business Daily X

4 weeks First American Bank Has $4.18 Million Stake in Amgen Inc. (NASDAQ:AMGN)MarketBeat X

4 weeks Zacks Research Forecasts Amgen’s Q1 Earnings (NASDAQ:AMGN)MarketBeat X

1 month Amgen Inc. Declares Quarterly Dividend of $2.25 (NASDAQ:AMGN)MarketBeat X

1 month Amgen Q3 Earnings Review: So Many Questions, But MariTide Data Top Of The ListSeeking Alpha X

1 month Amgen Gears Up to Report Q3 Earnings: Here’s What to ExpectZacks X

1 month Allspring Global Investments Holdings LLC Sells 11,091 Shares of Amgen Inc. (NASDAQ:AMGN)MarketBeat X

1 month Amgen (NASDAQ:AMGN) Stock Rating Reaffirmed by Cantor FitzgeraldMarketBeat X

1 month Amgen Inc. (NASDAQ:AMGN) Shares Sold by Raleigh Capital Management Inc.MarketBeat X

1 month Why Amgen (AMGN) Dipped More Than Broader Market TodayZacks X

1 month Amgen (NASDAQ:AMGN) Price Target Raised to $383.00MarketBeat X

1 month Penn Davis Mcfarland Inc. Raises Stake in Amgen Inc. (NASDAQ:AMGN)MarketBeat X

1 month Creative Planning Has $63.40 Million Stock Position in Amgen Inc. (NASDAQ:AMGN)MarketBeat X

1 month Raymond James & Associates Sells 71,201 Shares of Amgen Inc. (NASDAQ:AMGN)MarketBeat X